Argentine Foundation Requests Government Reject Patent Request For HIV Drug Made By Gilead
SciDev.Net: Argentine NGO objects to antiretroviral patent request
“An Argentine foundation has asked the National Institute of Industrial Property (INPI) to deny a patent request for an antiretroviral drug by the North American pharmaceutical company Gilead Sciences Inc. … In Brazil the same request by Gilead was rejected in 2017…” (De Ambrosio, 3/19).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.